
Innovative drug concept stocks rebound after hitting bottom, JZT reaches the daily limit
Innovative drug concept stocks rebound after hitting the bottom, JZT reaches the daily limit, ClinPlus rises over 10%, Medicilon, SDKX, and Hengrui Pharma all rise

